| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |